Course curriculum

    1. 13-valent pneumococcal (PCV13) vaccine in children (January 2020)

    2. ACE-inhibitor-associated cough (November 2022)

    3. Acute bronchitis (September 2022)

    4. Acute stridor in children - 2Qs (May 2020)

    5. Allergic asthma and immunotherapy (May 2025)

    6. Angiotensin-converting enzyme inhibitor cough (January 2023)

    7. Antibiotics and COPD (July 2020)

    8. Asthma guideline update - 2Qs (March 2021)

    9. Asthma - diagnosis - 2Qs (January 2020)

    10. Asthma - management - 2Qs (January 2020)

    11. Asthma in young children - 2Qs (January 2020)

    12. Asthma in young children - diagnosis - 3Qs (January 2025)

    13. Asthma treatment - 3Qs (July 2018)

    14. Bronchial thermoplasty (November 2019)

    15. Bronchiolitis - 3Qs (January 2025)

    16. Bronchiolitis - 4Qs (September 2020)

    17. Bronchopulmonary dysplasia - 2Qs (July 2023)

    18. Carbon monoxide exposure - 2Qs (September 2024)

    19. Central sleep apnea (January 2023)

    20. Chronic obstructive pulmonary disease - screening (November 2018)

    21. Community-acquired pneumonia - 2Qs (September 2024)

    22. Community-acquired pneumonia - 2Qs (March 2022)

    23. Community-acquired pneumonia in adults - outpatient - 2Qs (January 2020)

    24. Community-acquired pneumonia - inpatient - 2Qs (January 2020)

    25. Continuous positive airway pressure (CPAP) (March 2025)

    26. COPD and Roflumilast (September 2018)

    27. COPD maintenance therapy - 2Qs (July 2022)

    28. Corticosteroid use for COPD exacerbations (May 2022)

    29. Cough - postinfectious (January 2019)

    30. C-reactive protein - 2Qs (January 2024)

    31. Cystic fibrosis - 3Qs (January 2023)

    32. Drowning (September 2019)

    33. Drug induced lung injury -2 Qs (March 2023)

    34. Drug-induced lung injury - 3Qs (November 2019)

    35. Dyspnea at the end of life (November 2024)

    36. Emphysema - 2Qs (January 2025)

    37. Exercise-induced bronchospasm (January 2022)

    38. Human metapneumovirus (January 2020)

    39. Inhaled antimuscarinics - 2Qs (March 2020)

    40. Inhaled medications for COPD - 3Qs (July 2023)

    41. Easy practice improvement - COPD - 5Qs (January 2023)

    42. Eustachian tube dysfunction (November 2019)

    43. Inhaled steroids in COPD (September 2019)

    44. Latent tuberculosis - 2Qs (March 2019)

    45. Legionella - 2Qs (November 2020)

    46. Low intensity smoking - 2Qs (May 2023)

    47. Lung abscess (September 2022)

    48. Lung cancer - 4Qs (January 2019)

    49. Lung cancer in persons who never smoked (July 2024)

    50. Lung cancer in nonsmokers - 3Qs (September 2019)

    51. Lung cancer - screening (September 2022)

    52. Lung cancer screening - 3Qs (November 2021)

    53. Mesothelioma (July 2021)

    54. Mycobacterium Avium Complex - 2Qs (July 2019)

    55. Noninvasive positive pressure ventilation (September 2020)

    56. Obstructive disordered breathing in children - 2Qs (September 2020)

    57. Obstructive sleep apnea - 5Qs (July 2024)

    58. Obstructive sleep apnea - 2Qs (November 2020)

    59. Obstructive sleep apnea in children - 2Qs (May 2023)

    60. Occupational asthma (November 2022)

    61. Occupational asthma - 2Qs (July 2021)

    62. Post-infectious cough (November 2022)

    63. Pleural effusion - 3Qs (November 2020)

    64. Pleural effusion - 3Qs (May 2019)

    65. Pneumococcal conjugate vaccine - 13 valent (November 2020)

    66. Pneumococcal conjugate vaccine in adults (November 2020)

    67. Pneumonia - atypical - 2 Qs (January 2023)

    68. Preventing atopic disease (September 2021)

    69. Pulmonary embolism - diagnosis - 2Qs (May 2020)

    70. Pulmonary embolism - incidental (January 2019)

    71. Pulmonary embolism - subsegmental - 2Qs (March 2019)

    72. Pulmonary hypertension - 3Qs (March 2022)

    73. Pulmonary rehabilitation (July 2022)

    74. Pulmonary sarcoidosis - 3Qs (May 2020)

    75. Rapid-onset asthma - 3Qs (May 2025)

    76. Respiratory Syncytial Virus - 2Qs (September 2019)

    77. Rheumatoid arthritis-associated lung disease (July 2019)

    78. Risk assessment for community acquired pneumonia (September 2020)

    79. Sleep apnea in children (May 2019)

    80. Stridor in children - 5Qs (July 2021)

    81. Stridor in infants - 4Qs (May 2020)

    82. Supplemental Oxygen - Choosing Wisely (March 2023)

    83. Thrombolysis in pulmonary embolism - 2Qs (September 2021)

    84. Treatment of Wheezing - 8Qs (September 2022)

About this course

  • Free
  • 84 lessons
  • 0 hours of video content